Evodiamine and rutaecarpine inhibit migration by LIGHT via suppression of NADPH oxidase activation

Journal of Cellular Biochemistry

Volumn 107, Issue 1, 2009, Pages 123-133

  Heo, Sook Kyoung ^a   Yun, Hyun Jeong ^a   Yi, Hyo Seung ^a   Noh, Eui Kyu ^b   Park, Sun Dong ^a  

^a Dongguk University   (South Korea)

^b University of Ulsan College of Medicine   (South Korea)

Author keywords

Anti atherosclerosis; Evodiamine; Light; Migration; Rutaecarpine

Indexed keywords

CHEMOKINE RECEPTOR CCR1; CHEMOKINE RECEPTOR CCR2; EVODIAMINE; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; INTERLEUKIN 8; LIGHT PROTEIN; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; REACTIVE OXYGEN METABOLITE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE P40PHOX; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE OXIDASE P47PHOX; RUTAECARPINE; T LYMPHOCYTE RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXICITY; DOWN REGULATION; DRUG EFFECT; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HUMAN; HUMAN CELL; MIGRATION INHIBITION; PRIORITY JOURNAL;

CELL LINE; CELL MOVEMENT; ENZYME ACTIVATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FLOW CYTOMETRY; HUMANS; IMMUNOBLOTTING; INDOLE ALKALOIDS; INTERCELLULAR ADHESION MOLECULE-1; MONOCYTES; NADPH OXIDASE; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PHOSPHOPROTEINS; PHOSPHORYLATION; PLANT EXTRACTS; PROTEIN-SERINE-THREONINE KINASES; QUINAZOLINES; REACTIVE OXYGEN SPECIES; RECEPTORS, CCR2; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14;

EVODIA;

EID: 66149189450     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.22109     Document Type: Article

References (31)

1. Bobik A, Kalinina N. 2001. Tumor necrosis factor receptor and ligand superfamily family members TNFRSF14 and LIGHT: New players in human atherogenesis. Arterioscler Thromb Vasc Biol 21:1873-1875.
2. Crowe PD, VanArsdale TL, Walter BN, Ware CF, Hession C, Ehrenfels B, Browning JL, Din WS, Goodwin RG, Smith CA. 1994. A lymphotoxin-beta-specific receptor. Science 264:707-710.
3. Fan J, Watanabe T. 2003. Inflammatory reactions in the pathogenesis of atherosclerosis. J Atheroscler Thromb 10:63-71.
4. Fei XF, Wang BX, Li TJ, Tashiro S, Minami M, Xing DJ, Ikejima T. 2003. Evodiamine, a constituent of Evodiae Fructus, induces anti-proliferating effects in tumor cells. Cancer Sci 94:92-98.
5. Griendling KK, Sorescu D, Lassègue B, Ushio-Fukai M. 2000. Modulation of protein kinase activity and gene expression by reactive oxygen species and their role in vascular physiology and pathophysiology. Arterioscler Thromb Vasc Biol 20:2175-2183.
6. Heo SK, Ju SA, Lee SC, Park SM, Choe SY, Kwon B, Kwon BS, Kim BS. 2006. LIGHT enhances the bactericidal activity of human monocytes and neutrophils via HVEM. J Leukoc Biol 79:330-338.
7. Heo SK, Yoon MA, Lee SC, Ju SA, Choi JH, Suh PG, Kwon BS, Kim BS. 2007. HVEM signaling in monocytes is mediated by intracellular calcium mobilization. J Immunol 179:6305-6310.
8. Heo SK, Yun HJ, Park WH, Park SD. 2008. NADPH oxidase activation is required for migration by LIGHT in human monocytes. Biochem Biophys Res Commun 371:834-840.
9. Huang YC, Guh JH, Teng CM. 2004. Induction of mitotic arrest and apoptosis by evodiamine in human leukemic T-lymphocytes. Life Sci 75:35-49.
10. Ikeda U, Shimada K. 2001. Elevated circulating levels of monocyte chemoattractant protein-1 in patients with restenosis after coronary angioplasty. Arterioscler Thromb Vasc Biol 21:1090-1091.
11. Ikeda U, Ito T, Shimada K. 2001. Interleukin-6 and acute coronary syndrome. Clin Cardiol 24:701-704.
12. Ikeda U, Matsui K, Murakami Y, Shimada K. 2002. Monocyte chemoattractant protein-1 and coronary artery disease. Clin Cardiol 25:143-147.
13. Iwata H, Tezuka Y, Kadota S, Hiratsuka A, Watabe T. 2005. Mechanism-based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract. Drug Metab Pharmacokinet 20:34-45.
14. Kan SF, Yu CH, Pu HF, Hsu JM, Chen MJ, Wang PS. 2007. Anti-proliferative effects of evodiamine on human prostate cancer cell lines DU145 and PC3. J Cell Biochem 101:44-56.
15. Ko HC, Wang YH, Liou KT, Chen CM, Chen CH, Wang WY, Chang S, Hou YC, Chen KT, Chen CF, Shen YC. 2007. Anti-inflammatory effects and mechanisms of the ethanol extract of Evodia rutaecarpa and its bioactive components on neutrophils and microglial cells. Eur J Pharmacol 555:211-217.
16. Lee WH, Kim SH, Lee Y, Lee BB, Kwon B, Song H, Kwon BS, Park JE. 2001. Tumor necrosis factor receptor superfamily 14 is involved in atherogenesis by inducing proinflammatory cytokines and matrix metalloproteinases. Arterioscler Thromb Vasc Biol 21:2004-2010.
17. Lee TJ, Kim EJ, Kim S, Jung EM, Park JW, Jeong SH, Park SE, Yoo YH, Kwon TK. 2006. Caspase-dependent and caspase-independent apoptosis induced by evodiamine in human leukemic U937 cells. Mol Cancer Ther 5:2398-2407.
18. Mauri DN, Ebner R, Montgomery RI, Kochel KD, Cheung TC, Yu GL, Ruben S, Murphy M, Eisenberg RJ, Cohen GH, Spear PG, Ware CF. 1998. LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8:21-30.
19. Murphy M, Walter BN, Pike-Nobile L, Fanger NA, Guyre PM, Browning JL, Ware CF, Epstein LB. 1998. Expression of the lymphotoxin beta receptor on follicular stromal cells in human lymphoid tissues. Cell Death Differ 5:497-505.
20. Murphy KM, Nelson CA, Sedý JR. 2006. Balancing co-stimulation and inhibition with BTLA and HVEM. Nat Rev Immunol 6:671-681.
21. Rakesh K, Agrawal DK. 2005. Cytokines and growth factors involved in apoptosis and proliferation of vascular smooth muscle cells. Int Immunopharmacol 5:1487-1506.
22. Ross R. 1995. Cell biology of atherosclerosis. Annu Rev Physiol 57:791-804.
23. Ross R. 1999. Atherosclerosis is an inflammatory disease. Am Heart J 138:S419-S420.
24. Sedy JR, Gavrieli M, Potter KG, Hurchla MA, Lindsley RC, Hildner K, Scheu S, Pfeffer K, Ware CF, Murphy TL, Murphy KM. 2005. B and T lymphocyte attenuator regulates T cell activation through interaction with herpesvirus entry mediator. Nat Immunol 6:90-98.
25. Shaikh RB, Santee S, Granger SW, Butrovich K, Cheung T, Kronenberg M, Cheroutre H, Ware CF. 2001. Constitutive expression of LIGHT on T cells leads to lymphocyte activation, inflammation, and tissue destruction. J Immunol 167:6330-6337.
26. Shin YW, Bae EA, Cai XF, Lee JJ, Kim DH. 2007. In vitro and in vivo antiallergic effect of the fructus of Evodia rutaecarpa and its constituents. Biol Pharm Bull 30:197-199.
27. Takada Y, Kobayashi Y, Aggarwal BB. 2005. Evodiamine abolishes constitutive and inducible NF-kappaB activation by inhibiting IkappaBalpha kinase activation, thereby suppressing NF-kappaB-regulated antiapoptotic and metastatic gene expression, up-regulating apoptosis, and inhibiting invasion. J Biol Chem 280:17203-17212. (Pubitemid 41389187)
28. Tipping PG, Hancock WW. 1993. Production of tumor necrosis factor and interleukin-1 by macrophages from human atherosclerotic plaques. Am J Pathol 142:1721-1728.
29. Watts TH. 2005. TNF/TNFR family members in costimulation of T cell responses. Annu Rev Immunol 23:23-68.
30. Wei CY, Chou YH, Ho FM, Hsieh SL, Lin WW. 2006. Signaling pathways of LIGHT induced macrophage migration and vascular smooth muscle cell proliferation. J Cell Physiol 209:735-743.
31. Yarosh DB, Galvin JW, Nay SL, Peña AV, Canning MT, Brown DA. 2006. Anti-inflammatory activity in skin by biomimetic of Evodia rutaecarpa extract from traditional Chinese medicine. J Dermatol Sci 42:13-21.